QUEBEC CITY– Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, today announced the appointment of Ms. Viktoria Krasteva as Chief Financial Officer of the Corporation and the newest member of the corporate leadership team. Ms. Krasteva is scheduled to begin in this role on February 17, 2025, replacing Ms. Colette Laurin, interim Chief Financial Officer of the Corporation, who has agreed to stay on temporarily to help with a smooth transition.
“We are excited to have Viktoria joining Devonian at such a pivotal stage of our growth,” said Mr. Luc Gregoire, Devonian’s Chief Executive Officer. “Viktoria’s demonstrated financial and strategic leadership in healthcare and technology companies, coupled with her experience in financial markets, both private and public, will be instrumental in shepherding Devonian through its next stage of growth.”
Ms. Krasteva brings to Devonian about 20 years of financial management and strategic leadership, with varied experience with financial capital markets across different industries including life sciences digital media and online services. She is a chartered professional accountant (CPA) and holds a bachelor’s degree in international commerce from the University of World Economy in Bulgaria and has graduate degrees in Public Accountancy from the universities of Concordia and McGill.
“I am inspired and thrilled to be joining the Devonian team at such a critical juncture of opportunity for the Corporation,” said Ms. Krasteva. “I look forward to leveraging my experience in leading companies through different stages of growth to help us execute in reaching the next level.”
